{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:36:38Z","timestamp":1790613398100,"version":"4.1.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,3,28]],"date-time":"2015-03-28T00:00:00Z","timestamp":1427500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s40618-015-0261-3","type":"journal-article","created":{"date-parts":[[2015,3,29]],"date-time":"2015-03-29T01:25:02Z","timestamp":1427592302000},"page":"577-593","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism"],"prefix":"10.1007","volume":"38","author":[{"given":"C.","family":"Marcocci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Scillitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Corbetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Faggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Gianotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Migliaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Minisola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,28]]},"reference":[{"issue":"25","key":"261_CR1","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1106636","volume":"365","author":"C Marcocci","year":"2011","unstructured":"Marcocci C, Cetani F (2011) Clinical practice. Primary hyperparathyroidism. N Engl J Med 365(25):2389\u20132397. doi: 10.1056\/NEJMcp1106636","journal-title":"N Engl J Med"},{"issue":"10","key":"261_CR2","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 99(10):3561\u20133569. doi: 10.1210\/jc.2014-1413","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"261_CR3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1210\/jc.2007-1907","volume":"93","author":"BA Swiglo","year":"2008","unstructured":"Swiglo BA, Murad MH, Schunemann HJ, Kunz R, Vigersky RA, Guyatt GH, Montori VM (2008) A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metab 93(3):666\u2013673. doi: 10.1210\/jc.2007-1907","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"261_CR4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3109\/02813432.2013.861152","volume":"31","author":"S Dalemo","year":"2013","unstructured":"Dalemo S, Eggertsen R, Hjerpe P, Jansson S, Almqvist EG, Bengtsson Bostrom K (2013) Long-term follow-up of patients with elevated serum calcium concentrations in Swedish primary care. Scand J Prim Health Care 31(4):248\u2013254. doi: 10.3109\/02813432.2013.861152","journal-title":"Scand J Prim Health Care"},{"key":"261_CR5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1138\/20110522","volume":"8","author":"J Bollerslev","year":"2011","unstructured":"Bollerslev J, Rolighed L, Mosekilde L (2011) Mild primary hyperparathyroidism and metabolism of vitamin D. IBMS BoneKEy 8:342\u2013351","journal-title":"IBMS BoneKEy"},{"issue":"6","key":"261_CR6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.semnephrol.2011.09.008","volume":"31","author":"M Grieff","year":"2011","unstructured":"Grieff M, Bushinsky DA (2011) Diuretics and disorders of calcium homeostasis. Semin Nephrol 31(6):535\u2013541. doi: 10.1016\/j.semnephrol.2011.09.008","journal-title":"Semin Nephrol"},{"issue":"4","key":"261_CR7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2174\/157340612801216139","volume":"8","author":"F Lumachi","year":"2012","unstructured":"Lumachi F, Cappelletti P, Tozzoli R, Basso SM, Luisetto G, Camozzi V (2012) Diagnosis of alterations of serum calcium metabolism. Med Chem 8(4):551\u2013555","journal-title":"Med Chem"},{"key":"261_CR8","doi-asserted-by":"crossref","unstructured":"Wermers RA, Kearns AE, Jenkins GD, Melton LJ 3rd (2007) Incidence and clinical spectrum of thiazide-associated hypercalcemia. Am J Med 120 (10):911 e919\u2013915. doi: 10.1016\/j.amjmed.2006.07.044","DOI":"10.1016\/j.amjmed.2006.07.044"},{"issue":"2","key":"261_CR9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4158\/EP.2.2.103","volume":"2","author":"CR McHenry","year":"1996","unstructured":"McHenry CR, Lee K (1996) Lithium therapy and disorders of the parathyroid glands. Endocr Pract 2(2):103\u2013109. doi: 10.4158\/EP.2.2.103","journal-title":"Endocr Pract"},{"issue":"9","key":"261_CR10","first-page":"2844","volume":"82","author":"ST Haden","year":"1997","unstructured":"Haden ST, Stoll AL, McCormick S, Scott J, Ge-H Fuleihan (1997) Alterations in parathyroid dynamics in lithium-treated subjects. J Clin Endocrinol Metab 82(9):2844\u20132848. doi: 10.1210\/jcem.82.9.4218","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"261_CR11","first-page":"15","volume":"106","author":"J Lally","year":"2013","unstructured":"Lally J, Lee B, McDonald C (2013) Prevalence of hypercalcaemia in patients on maintenance lithium therapy monitored in primary care. Ir Med J 106(1):15\u201317","journal-title":"Ir Med J"},{"issue":"5","key":"261_CR12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2265.2008.03259.x","volume":"69","author":"SE Christensen","year":"2008","unstructured":"Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Brixen K, Mosekilde L (2008) Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods. Clin Endocrinol (Oxf) 69(5):713\u2013720. doi: 10.1111\/j.1365-2265.2008.03259.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"261_CR13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s12630-011-9601-8","volume":"59","author":"J Mackenzie-Feder","year":"2012","unstructured":"Mackenzie-Feder J, Tsang J, Demyttenaere S (2012) Unsuspected pheochromocytoma: is it time for a registry? Can J Anaesth 59(1):112\u2013113. doi: 10.1007\/s12630-011-9601-8","journal-title":"Can J Anaesth"},{"issue":"9","key":"261_CR14","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1210\/jc.2012-1429","volume":"97","author":"GS Ong","year":"2012","unstructured":"Ong GS, Walsh JP, Stuckey BG, Brown SJ, Rossi E, Ng JL, Nguyen HH, Kent GN, Lim EM (2012) The importance of measuring ionized calcium in characterizing calcium status and diagnosing primary hyperparathyroidism. J Clin Endocrinol Metab 97(9):3138\u20133145. doi: 10.1210\/jc.2012-1429","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"261_CR15","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/cen.12210","volume":"79","author":"F Tassone","year":"2013","unstructured":"Tassone F, Gianotti L, Baffoni C, Visconti G, Pellegrino M, Cassibba S, Croce CG, Magro G, Cesario F, Attanasio R, Borretta G (2013) Vitamin D status in primary hyperparathyroidism: a Southern European perspective. Clin Endocrinol (Oxf) 79(6):784\u2013790. doi: 10.1111\/cen.12210","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"261_CR16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.bone.2010.06.013","volume":"47","author":"V Carnevale","year":"2010","unstructured":"Carnevale V, Nieddu L, Romagnoli E, Battista C, Mascia ML, Chiodini I, Eller-Vainicher C, Frusciante V, Santini SA, La Porta M, Minisola S, Scillitani A (2010) Regulation of PTH secretion by 25-hydroxyvitamin D and ionized calcium depends on vitamin D status: a study in a large cohort of healthy subjects. Bone 47(3):626\u2013630. doi: 10.1016\/j.bone.2010.06.013","journal-title":"Bone"},{"issue":"6","key":"261_CR17","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1530\/EJE-11-0589","volume":"165","author":"J Bollerslev","year":"2011","unstructured":"Bollerslev J, Marcocci C, Sosa M, Nordenstrom J, Bouillon R, Mosekilde L (2011) Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. Eur J Endocrinol 165(6):851\u2013864. doi: 10.1530\/EJE-11-0589","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"261_CR18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0002-9343(02)01306-2","volume":"113","author":"SJ Silverberg","year":"2002","unstructured":"Silverberg SJ, Brown I, Bilezikian JP (2002) Age as a criterion for surgery in primary hyperparathyroidism. Am J Med 113(8):681\u2013684","journal-title":"Am J Med"},{"issue":"4","key":"261_CR19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00774-012-0399-4","volume":"31","author":"AM Egan","year":"2013","unstructured":"Egan AM, Ryan J, Aziz MA, O\u2019Dwyer TP, Byrne MM (2013) Primary hyperparathyroidism in a patient with familial hypocalciuric hypercalcaemia due to a novel mutation in the calcium-sensing receptor gene. J Bone Miner Metab 31(4):477\u2013480. doi: 10.1007\/s00774-012-0399-4","journal-title":"J Bone Miner Metab"},{"issue":"Pt 2","key":"261_CR20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1258\/acb.2010.010202","volume":"48","author":"CN Jayasena","year":"2011","unstructured":"Jayasena CN, Mahmud M, Palazzo F, Donaldson M, Meeran K, Dhillo WS (2011) Utility of the urine calcium-to-creatinine ratio to diagnose primary hyperparathyroidism in asymptomatic hypercalcaemic patients with vitamin D deficiency. Ann Clin Biochem 48(Pt 2):126\u2013129. doi: 10.1258\/acb.2010.010202","journal-title":"Ann Clin Biochem"},{"issue":"6","key":"261_CR21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1530\/EJE-08-0440","volume":"159","author":"SE Christensen","year":"2008","unstructured":"Christensen SE, Nissen PH, Vestergaard P, Heickendorff L, Rejnmark L, Brixen K, Mosekilde L (2008) Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism. Eur J Endocrinol 159(6):719\u2013727. doi: 10.1530\/EJE-08-0440","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"261_CR22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00223-011-9517-x","volume":"89","author":"T Isaksen","year":"2011","unstructured":"Isaksen T, Nielsen CS, Christensen SE, Nissen PH, Heickendorff L, Mosekilde L (2011) Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study. Calcif Tissue Int 89(4):285\u2013294. doi: 10.1007\/s00223-011-9517-x","journal-title":"Calcif Tissue Int"},{"issue":"7 Suppl","key":"261_CR23","first-page":"2","volume":"35","author":"M Zini","year":"2012","unstructured":"Zini M, Attanasio R, Cesareo R, Emmolo I, Frasoldati A, Gianotti L, Guglielmi R, Piovesan A, Procopio M, Scillitani A, Versari A, Bollerslev J, Rao DS, Marcocci C, Borretta G, Italian Association of Clinical E (2012) AME position statement: primary hyperparathyroidism in clinical practice. J Endocrinol Invest 35(7 Suppl):2\u201321","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"261_CR24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4158\/EP12284.RA","volume":"19","author":"MC Shinall Jr","year":"2013","unstructured":"Shinall MC Jr, Dahir KM, Broome JT (2013) Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism. Endocr Pract 19(4):697\u2013702. doi: 10.4158\/EP12284.RA","journal-title":"Endocr Pract"},{"issue":"7","key":"261_CR25","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","volume":"75","author":"MR Pollak","year":"1993","unstructured":"Pollak MR, Brown EM, Chou YH, Hebert SC, Marx SJ, Steinmann B, Levi T, Seidman CE, Seidman JG (1993) Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75(7):1297\u20131303","journal-title":"Cell"},{"issue":"26","key":"261_CR26","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","volume":"368","author":"MA Nesbit","year":"2013","unstructured":"Nesbit MA, Hannan FM, Howles SA, Babinsky VN, Head RA, Cranston T, Rust N, Hobbs MR, Heath H 3rd, Thakker RV (2013) Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia. N Engl J Med 368(26):2476\u20132486. doi: 10.1056\/NEJMoa1300253","journal-title":"N Engl J Med"},{"issue":"1","key":"261_CR27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ng.2492","volume":"45","author":"MA Nesbit","year":"2013","unstructured":"Nesbit MA, Hannan FM, Howles SA, Reed AA, Cranston T, Thakker CE, Gregory L, Rimmer AJ, Rust N, Graham U, Morrison PJ, Hunter SJ, Whyte MP, McVean G, Buck D, Thakker RV (2013) Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3. Nat Genet 45(1):93\u201397. doi: 10.1038\/ng.2492","journal-title":"Nat Genet"},{"issue":"8","key":"261_CR28","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1359\/jbmr.090304","volume":"24","author":"C Eller-Vainicher","year":"2009","unstructured":"Eller-Vainicher C, Chiodini I, Battista C, Viti R, Mascia ML, Massironi S, Peracchi M, D\u2019Agruma L, Minisola S, Corbetta S, Cole DE, Spada A, Scillitani A (2009) Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity. J Bone Miner Res 24(8):1404\u20131410. doi: 10.1359\/jbmr.090304","journal-title":"J Bone Miner Res"},{"issue":"8","key":"261_CR29","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1210\/jc.2006-2843","volume":"92","author":"M Georgitsi","year":"2007","unstructured":"Georgitsi M, Raitila A, Karhu A, van der Luijt RB, Aalfs CM, Sane T, Vierimaa O, Makinen MJ, Tuppurainen K, Paschke R, Gimm O, Koch CA, Gundogdu S, Lucassen A, Tischkowitz M, Izatt L, Aylwin S, Bano G, Hodgson S, De Menis E, Launonen V, Vahteristo P, Aaltonen LA (2007) Germline CDKN1B\/p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab 92(8):3321\u20133325. doi: 10.1210\/jc.2006-2843","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"261_CR30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/EJE-11-0929","volume":"166","author":"D Malanga","year":"2012","unstructured":"Malanga D, De Gisi S, Riccardi M, Scrima M, De Marco C, Robledo M, Viglietto G (2012) Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype. Eur J Endocrinol 166(3):551\u2013560. doi: 10.1530\/EJE-11-0929","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"261_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EC-14-0116","volume":"2015","author":"E Pardi","year":"2014","unstructured":"Pardi E, Mariotti S, Pellegata NS, Benfini K, Borsari S, Saponaro F, Torregrossa L, Cappai A, Satta C, Mastinu M, Marcocci C, Cetani F (2014) Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 (MEN4). Endocr Connect 2015(4):1\u20138. doi: 10.1530\/EC-14-0116","journal-title":"Endocr Connect"},{"issue":"Suppl1","key":"261_CR32","first-page":"S1","volume":"6","author":"M Alevizaki","year":"2013","unstructured":"Alevizaki M (2013) Management of hyperparathyrodism (PHP) in MEN2 syndrome in Europe. Thyroid Res 6(Suppl1):S1\u2013S10. doi: 10.1186\/1756-6614-6-S1-S10","journal-title":"Thyroid Res"},{"issue":"4","key":"261_CR33","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1677\/ERC-08-0066","volume":"15","author":"G Masi","year":"2008","unstructured":"Masi G, Barzon L, Iacobone M, Viel G, Porzionato A, Macchi V, De Caro R, Favia G, Palu G (2008) Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism. Endocr Relat Cancer 15(4):1115\u20131126. doi: 10.1677\/ERC-08-0066","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"261_CR34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2265.2011.04059.x","volume":"75","author":"K Frank-Raue","year":"2011","unstructured":"Frank-Raue K, Leidig-Bruckner G, Haag C, Schulze E, Lorenz A, Schmitz-Winnenthal H, Raue F (2011) Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf) 75(1):50\u201355. doi: 10.1111\/j.1365-2265.2011.04059.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"261_CR35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/humu.21188","volume":"31","author":"PJ Newey","year":"2010","unstructured":"Newey PJ, Bowl MR, Cranston T, Thakker RV (2010) Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism\u2013jaw tumor syndrome (HPT\u2013JT) and parathyroid tumors. Hum Mutat 31(3):295\u2013307. doi: 10.1002\/humu.21188","journal-title":"Hum Mutat"},{"issue":"2","key":"261_CR36","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2265.2006.02438.x","volume":"64","author":"F Cetani","year":"2006","unstructured":"Cetani F, Pardi E, Ambrogini E, Lemmi M, Borsari S, Cianferotti L, Vignali E, Viacava P, Berti P, Mariotti S, Pinchera A, Marcocci C (2006) Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management. Clin Endocrinol (Oxf) 64(2):146\u2013152. doi: 10.1111\/j.1365-2265.2006.02438.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"261_CR37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2265.2006.02534.x","volume":"65","author":"N Mizusawa","year":"2006","unstructured":"Mizusawa N, Uchino S, Iwata T, Tsuyuguchi M, Suzuki Y, Mizukoshi T, Yamashita Y, Sakurai A, Suzuki S, Beniko M, Tahara H, Fujisawa M, Kamata N, Fujisawa K, Yashiro T, Nagao D, Golam HM, Sano T, Noguchi S, Yoshimoto K (2006) Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome. Clin Endocrinol (Oxf) 65(1):9\u201316. doi: 10.1111\/j.1365-2265.2006.02534.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1\u20132","key":"261_CR38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12672-011-0100-8","volume":"3","author":"LF Starker","year":"2012","unstructured":"Starker LF, Akerstrom T, Long WD, Delgado-Verdugo A, Donovan P, Udelsman R, Lifton RP, Carling T (2012) Frequent germ-line mutations of the MEN1, CASR, and HRPT2\/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism. Horm Cancer 3(1\u20132):44\u201351. doi: 10.1007\/s12672-011-0100-8","journal-title":"Horm Cancer"},{"issue":"7","key":"261_CR39","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2008-2006","volume":"94","author":"E Vignali","year":"2009","unstructured":"Vignali E, Viccica G, Diacinti D, Cetani F, Cianferotti L, Ambrogini E, Banti C, Del Fiacco R, Bilezikian JP, Pinchera A, Marcocci C (2009) Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 94(7):2306\u20132312. doi: 10.1210\/jc.2008-2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"261_CR40","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1210\/jc.2008-1758","volume":"94","author":"R Eastell","year":"2009","unstructured":"Eastell R, Arnold A, Brandi ML, Brown EM, D\u2019Amour P, Hanley DA, Rao DS, Rubin MR, Goltzman D, Silverberg SJ, Marx SJ, Peacock M, Mosekilde L, Bouillon R, Lewiecki EM (2009) Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94(2):340\u2013350. doi: 10.1210\/jc.2008-1758","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"261_CR41","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1210\/jc.2013-3978","volume":"99","author":"L Rolighed","year":"2014","unstructured":"Rolighed L, Rejnmark L, Sikjaer T, Heickendorff L, Vestergaard P, Mosekilde L, Christiansen P (2014) Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J Clin Endocrinol Metab 99(3):1072\u20131080. doi: 10.1210\/jc.2013-3978","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"261_CR42","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/cen.12398","volume":"80","author":"VN Shah","year":"2014","unstructured":"Shah VN, Shah CS, Bhadada SK, Rao DS (2014) Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature. Clin Endocrinol (Oxf) 80(6):797\u2013803. doi: 10.1111\/cen.12398","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"261_CR43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF03345354","volume":"28","author":"S Corbetta","year":"2005","unstructured":"Corbetta S, Baccarelli A, Aroldi A, Vicentini L, Fogazzi GB, Eller-Vainicher C, Ponticelli C, Beck-Peccoz P, Spada A (2005) Risk factors associated to kidney stones in primary hyperparathyroidism. J Endocrinol Invest 28(2):122\u2013128","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"261_CR44","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s002239900728","volume":"65","author":"DH Gutteridge","year":"1999","unstructured":"Gutteridge DH, Gruber HE, Kermode DG, Worth GK (1999) Thirty cases of concurrent Paget\u2019s disease and primary hyperparathyroidism: sex distribution, histomorphometry, and prediction of the skeletal response to parathyroidectomy. Calcif Tissue Int 65(6):427\u2013435","journal-title":"Calcif Tissue Int"},{"issue":"11","key":"261_CR45","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1210\/jc.2009-0587","volume":"94","author":"F Tassone","year":"2009","unstructured":"Tassone F, Gianotti L, Emmolo I, Ghio M, Borretta G (2009) Glomerular filtration rate and parathyroid hormone secretion in primary hyperparathyroidism. J Clin Endocrinol Metab 94(11):4458\u20134461. doi: 10.1210\/jc.2009-0587","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"261_CR46","first-page":"693","volume":"19","author":"M Marangella","year":"2002","unstructured":"Marangella M, Petrarulo M, Daniele PG, Sammartano S (2002) LithoRisk: a software for calculating and visualising nephrolithiasis risk profiles. G Ital Nefrol 19(6):693\u2013698","journal-title":"G Ital Nefrol"},{"issue":"10","key":"261_CR47","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1210\/jc.2014-1415","volume":"99","author":"SJ Silverberg","year":"2014","unstructured":"Silverberg SJ, Clarke BL, Peacock M, Bandeira F, Boutroy S, Cusano NE, Dempster D, Lewiecki EM, Jian-Min L, Minisola S, Rejnmark L, Silva BC, Walker MD, Bilezikian JP (2014) Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 99(10):3580\u20133594. doi: 10.1210\/jc.2014-1415","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"261_CR48","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1210\/jc.2006-1178","volume":"91","author":"EM Lewiecki","year":"2006","unstructured":"Lewiecki EM, Laster AJ (2006) Clinical review: clinical applications of vertebral fracture assessment by dual-energy x-ray absorptiometry. J Clin Endocrinol Metab 91(11):4215\u20134222. doi: 10.1210\/jc.2006-1178","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"261_CR49","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1210\/jc.2006-0070","volume":"91","author":"L Gianotti","year":"2006","unstructured":"Gianotti L, Tassone F, Cesario F, Pia A, Razzore P, Magro G, Piovesan A, Borretta G (2006) A slight decrease in renal function further impairs bone mineral density in primary hyperparathyroidism. J Clin Endocrinol Metab 91(8):3011\u20133016. doi: 10.1210\/jc.2006-0070","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"261_CR50","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1210\/jc.2011-3072","volume":"97","author":"MD Walker","year":"2012","unstructured":"Walker MD, Dempster DW, McMahon DJ, Udesky J, Shane E, Bilezikian JP, Silverberg SJ (2012) Effect of renal function on skeletal health in primary hyperparathyroidism. J Clin Endocrinol Metab 97(5):1501\u20131507. doi: 10.1210\/jc.2011-3072","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"261_CR51","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-14-0343","volume":"171","author":"C Eller-Vainicher","year":"2014","unstructured":"Eller-Vainicher C, Battista C, Guarnieri V, Muscarella S, Palmieri S, Salcuni AS, Guglielmi G, Corbetta S, Minisola S, Spada A, Hendy GN, Cole DE, Chiodini I, Scillitani A (2014) Factors associated with vertebral fracture risk in patients with primary hyperparathyroidism. Eur J Endocrinol 171(3):399\u2013406. doi: 10.1530\/EJE-14-0343","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"261_CR52","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bone.2012.11.041","volume":"53","author":"E Romagnoli","year":"2013","unstructured":"Romagnoli E, Cipriani C, Nofroni I, Castro C, Angelozzi M, Scarpiello A, Pepe J, Diacinti D, Piemonte S, Carnevale V, Minisola S (2013) \u201cTrabecular Bone Score\u201d (TBS): an indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism. Bone 53(1):154\u2013159. doi: 10.1016\/j.bone.2012.11.041","journal-title":"Bone"},{"issue":"1","key":"261_CR53","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jocd.2012.11.008","volume":"16","author":"MD Walker","year":"2013","unstructured":"Walker MD, Rubin M, Silverberg SJ (2013) Nontraditional manifestations of primary hyperparathyroidism. J Clin Densitom 16(1):40\u201347. doi: 10.1016\/j.jocd.2012.11.008","journal-title":"J Clin Densitom"},{"issue":"1","key":"261_CR54","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2265.2009.03766.x","volume":"73","author":"N Yu","year":"2010","unstructured":"Yu N, Donnan PT, Flynn RW, Murphy MJ, Smith D, Rudman A, Leese GP (2010) Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Oxf) 73(1):30\u201334. doi: 10.1111\/j.1365-2265.2009.03766.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"261_CR55","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1210\/jc.2008-2742","volume":"94","author":"J Bollerslev","year":"2009","unstructured":"Bollerslev J, Rosen T, Mollerup CL, Nordenstrom J, Baranowski M, Franco C, Pernow Y, Isaksen GA, Godang K, Ueland T, Jansson S, Group SS (2009) Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. J Clin Endocrinol Metab 94(7):2255\u20132261. doi: 10.1210\/jc.2008-2742","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"261_CR56","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2006-1836","volume":"92","author":"J Bollerslev","year":"2007","unstructured":"Bollerslev J, Jansson S, Mollerup CL, Nordenstrom J, Lundgren E, Torring O, Varhaug JE, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T (2007) Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92(5):1687\u20131692. doi: 10.1210\/jc.2006-1836","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"261_CR57","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1210\/jc.2004-0028","volume":"89","author":"DS Rao","year":"2004","unstructured":"Rao DS, Phillips ER, Divine GW, Talpos GB (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89(11):5415\u20135422. doi: 10.1210\/jc.2004-0028","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"261_CR58","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/jc.2007-0219","volume":"92","author":"E Ambrogini","year":"2007","unstructured":"Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, Oppo A, Miccoli P, Berti P, Bilezikian JP, Pinchera A, Marcocci C (2007) Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 92(8):3114\u20133121. doi: 10.1210\/jc.2007-0219","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"261_CR59","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1530\/EJE-13-0502","volume":"169","author":"C Blanchard","year":"2013","unstructured":"Blanchard C, Mathonnet M, Sebag F, Caillard C, Hamy A, Volteau C, Heymann MF, Wyart V, Drui D, Roy M, Cariou B, Archambeaud F, Rodien P, Henry JF, Zarnegar R, Hardouin JB, Mirallie E (2013) Surgery for \u2018asymptomatic\u2019 mild primary hyperparathyroidism improves some clinical symptoms postoperatively. Eur J Endocrinol 169(5):665\u2013672. doi: 10.1530\/EJE-13-0502","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"261_CR60","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","volume":"93","author":"MR Rubin","year":"2008","unstructured":"Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, Udesky J, Silverberg SJ (2008) The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab 93(9):3462\u20133470. doi: 10.1210\/jc.2007-1215","journal-title":"J Clin Endocrinol Metab"},{"key":"261_CR61","author":"K Lundstam","year":"2015","unstructured":"Lundstam K, Heck A, Mollerup C, Godang K, Baranowski M, Pernow Y, Erik Varhaug J, Hessman O, Rosen T, Nordenstrom J, Jansson S, Hellstrom M, Bollerslev J (2015) Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. J Clin Endocrinol Metab. doi: 10.1210\/jc.2014-3441","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"261_CR62","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4158\/EP14074.OR","volume":"20","author":"S Cassibba","year":"2014","unstructured":"Cassibba S, Pellegrino M, Gianotti L, Baffoni C, Baralis E, Attanasio R, Guarnieri A, Borretta G, Tassone F (2014) Silent renal stones in primary hyperparathyroidism: prevalence and clinical features. Endocr Pract 20(11):1137\u20131142. doi: 10.4158\/EP14074.OR","journal-title":"Endocr Pract"},{"issue":"8","key":"261_CR63","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1210\/jc.2011-0569","volume":"96","author":"L Rejnmark","year":"2011","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2011) Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab 96(8):2377\u20132385. doi: 10.1210\/jc.2011-0569","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"261_CR64","doi-asserted-by":"crossref","first-page":"956","DOI":"10.7326\/0003-4819-115-12-956","volume":"115","author":"NIH conference","year":"1991","unstructured":"NIH conference (1991) Gastrointestinal surgery for severe obesity. Consensus development conference panel. Ann Intern Med 115(12):956\u2013961","journal-title":"Ann Intern Med"},{"issue":"12","key":"261_CR65","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1210\/jc.2002-021370","volume":"87","author":"JP Bilezikian","year":"2002","unstructured":"Bilezikian JP, Potts JT Jr, Fuleihan Gel H, Kleerekoper M, Neer R, Peacock M, Rastad J, Silverberg SJ, Udelsman R, Wells SA (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 87(12):5353\u20135361. doi: 10.1210\/jc.2002-021370","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"261_CR66","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1210\/jc.2008-2574","volume":"94","author":"MD Walker","year":"2009","unstructured":"Walker MD, McMahon DJ, Inabnet WB, Lazar RM, Brown I, Vardy S, Cosman F, Silverberg SJ (2009) Neuropsychological features in primary hyperparathyroidism: a prospective study. J Clin Endocrinol Metab 94(6):1951\u20131958. doi: 10.1210\/jc.2008-2574","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"261_CR67","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","volume":"341","author":"SJ Silverberg","year":"1999","unstructured":"Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP (1999) A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341(17):1249\u20131255. doi: 10.1056\/NEJM199910213411701","journal-title":"N Engl J Med"},{"issue":"13","key":"261_CR68","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1245\/s10434-013-3190-4","volume":"20","author":"DF Schneider","year":"2013","unstructured":"Schneider DF, Burke JF, Ojomo KA, Clark N, Mazeh H, Sippel RS, Chen H (2013) Multigland disease and slower decline in intraoperative PTH characterize mild primary hyperparathyroidism. Ann Surg Oncol 20(13):4205\u20134211. doi: 10.1245\/s10434-013-3190-4","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"261_CR69","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1210\/jc.2014-2000","volume":"99","author":"R Udelsman","year":"2014","unstructured":"Udelsman R, Akerstrom G, Biagini C, Duh QY, Miccoli P, Niederle B, Tonelli F (2014) The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 99(10):3595\u20133606. doi: 10.1210\/jc.2014-2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"261_CR70","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1067\/msy.2002.119817","volume":"131","author":"AC Civelek","year":"2002","unstructured":"Civelek AC, Ozalp E, Donovan P, Udelsman R (2002) Prospective evaluation of delayed technetium-99\u00a0m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery 131(2):149\u2013157","journal-title":"Surgery"},{"issue":"11","key":"261_CR71","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1007\/s00268-004-7485-2","volume":"28","author":"R Husen Van","year":"2004","unstructured":"Van Husen R, Kim LT (2004) Accuracy of surgeon-performed ultrasound in parathyroid localization. World J Surg 28(11):1122\u20131126. doi: 10.1007\/s00268-004-7485-2","journal-title":"World J Surg"},{"issue":"Suppl 2","key":"261_CR72","first-page":"S217","volume":"16","author":"S Goswami","year":"2012","unstructured":"Goswami S, Ghosh S (2012) Hyperparathyroidism: cancer and mortality. Indian J Endocrinol Metab 16(Suppl 2):S217\u2013S220. doi: 10.4103\/2230-8210.104042","journal-title":"Indian J Endocrinol Metab"},{"issue":"11","key":"261_CR73","doi-asserted-by":"crossref","first-page":"E1737","DOI":"10.1210\/jc.2011-1486","volume":"96","author":"RP Espiritu","year":"2011","unstructured":"Espiritu RP, Kearns AE, Vickers KS, Grant C, Ryu E, Wermers RA (2011) Depression in primary hyperparathyroidism: prevalence and benefit of surgery. J Clin Endocrinol Metab 96(11):E1737\u2013E1745. doi: 10.1210\/jc.2011-1486","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"261_CR74","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2265.2011.04197.x","volume":"76","author":"H Kahal","year":"2012","unstructured":"Kahal H, Aye M, Rigby AS, Sathyapalan T, England RJ, Atkin SL (2012) The effect of parathyroidectomy on neuropsychological symptoms and biochemical parameters in patients with asymptomatic primary hyperparathyroidism. Clin Endocrinol (Oxf) 76(2):196\u2013200. doi: 10.1111\/j.1365-2265.2011.04197.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"18","key":"261_CR75","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJM198510313131805","volume":"313","author":"KL Insogna","year":"1985","unstructured":"Insogna KL, Mitnick ME, Stewart AF, Burtis WJ, Mallette LE, Broadus AE (1985) Sensitivity of the parathyroid hormone-1,25-dihydroxyvitamin D axis to variations in calcium intake in patients with primary hyperparathyroidism. N Engl J Med 313(18):1126\u20131130. doi: 10.1056\/NEJM198510313131805","journal-title":"N Engl J Med"},{"issue":"6","key":"261_CR76","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00394-002-0383-1","volume":"41","author":"R Jorde","year":"2002","unstructured":"Jorde R, Szumlas K, Haug E, Sundsfjord J (2002) The effects of calcium supplementation to patients with primary hyperparathyroidism and a low calcium intake. Eur J Nutr 41(6):258\u2013263. doi: 10.1007\/s00394-002-0383-1","journal-title":"Eur J Nutr"},{"issue":"6","key":"261_CR77","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0002-9343(97)00053-3","volume":"102","author":"FG Locker","year":"1997","unstructured":"Locker FG, Silverberg SJ, Bilezikian JP (1997) Optimal dietary calcium intake in primary hyperparathyroidism. Am J Med 102(6):543\u2013550","journal-title":"Am J Med"},{"issue":"10","key":"261_CR78","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1210\/jc.2014-1417","volume":"99","author":"C Marcocci","year":"2014","unstructured":"Marcocci C, Bollerslev J, Khan AA, Shoback DM (2014) Medical management of primary hyperparathyroidism: proceedings of the Fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. J Clin Endocrinol Metab 99(10):3607\u20133618. doi: 10.1210\/jc.2014-1417","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"261_CR79","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s40618-014-0060-2","volume":"37","author":"S Minisola","year":"2014","unstructured":"Minisola S, Romagnoli E, Scillitani A, Rao SD (2014) Hypovitaminosis D in primary hyperparathyroidism: to treat or not to treat? That is the question. J Endocrinol Invest 37(5):413\u2013414. doi: 10.1007\/s40618-014-0060-2","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"261_CR80","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1530\/EJE-13-0435","volume":"169","author":"E Romagnoli","year":"2013","unstructured":"Romagnoli E, Pepe J, Piemonte S, Cipriani C, Minisola S (2013) Management of endocrine disease: value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation. Eur J Endocrinol 169(4):R59\u2013R69. doi: 10.1530\/EJE-13-0435","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"261_CR81","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s40618-014-0071-z","volume":"37","author":"E Romagnoli","year":"2014","unstructured":"Romagnoli E, Carnevale V, Biondi P, Minisola S (2014) Vitamin D supplementation: when and how? J Endocrinol Invest 37(7):603\u2013607. doi: 10.1007\/s40618-014-0071-z","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"261_CR82","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jocd.2012.11.010","volume":"16","author":"AA Khan","year":"2013","unstructured":"Khan AA (2013) Medical management of primary hyperparathyroidism. J Clin Densitom 16(1):60\u201363. doi: 10.1016\/j.jocd.2012.11.010","journal-title":"J Clin Densitom"},{"issue":"4","key":"261_CR83","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1210\/jc.2009-2384","volume":"95","author":"S Sankaran","year":"2010","unstructured":"Sankaran S, Gamble G, Bolland M, Reid IR, Grey A (2010) Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis. J Clin Endocrinol Metab 95(4):1653\u20131662. doi: 10.1210\/jc.2009-2384","journal-title":"J Clin Endocrinol Metab"},{"key":"261_CR84","unstructured":"EMA (2008) http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000570\/human_med_000903.jsp&mid=WC0p01ac058001d124 . Accessed 18 Nov 2013"},{"key":"261_CR85","unstructured":"FDA (2011) www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/021688s017lbl.pdf . Accessed 18 Nov 2013"},{"issue":"1","key":"261_CR86","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/cen.12108","volume":"79","author":"F Saponaro","year":"2013","unstructured":"Saponaro F, Faggiano A, Grimaldi F, Borretta G, Brandi ML, Minisola S, Frasoldati A, Papini E, Scillitani A, Banti C, Del Prete M, Vescini F, Gianotti L, Cavalli L, Romagnoli E, Colao A, Cetani F, Marcocci C (2013) Cinacalcet in the management of primary hyperparathyroidism: post marketing experience of an Italian multicentre group. Clin Endocrinol (Oxf) 79(1):20\u201326. doi: 10.1111\/cen.12108","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"261_CR87","first-page":"655","volume":"35","author":"F Cetani","year":"2012","unstructured":"Cetani F, Saponaro F, Banti C, Cianferotti L, Vignali E, Chiavistelli S, Viccica G, Pinchera A, Marcocci C (2012) Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling. J Endocrinol Invest 35(7):655\u2013660. doi: 10.3275\/7970","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"261_CR88","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s12020-013-9980-4","volume":"44","author":"G Diaz-Soto","year":"2013","unstructured":"Diaz-Soto G, Linglart A, Senat MV, Kamenicky P, Chanson P (2013) Primary hyperparathyroidism in pregnancy. Endocrine 44(3):591\u2013597. doi: 10.1007\/s12020-013-9980-4","journal-title":"Endocrine"},{"issue":"3","key":"261_CR89","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/08998280.2011.11928719","volume":"24","author":"M Som","year":"2011","unstructured":"Som M, Stroup JS (2011) Primary hyperparathyroidism and pregnancy. Proc (Bayl Univ Med Cent) 24(3):220\u2013223","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"8","key":"261_CR90","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1515\/JPEM.2009.22.8.741","volume":"22","author":"C Horjus","year":"2009","unstructured":"Horjus C, Groot I, Telting D, van Setten P, van Sorge A, Kovacs CS, Hermus A, de Boer H (2009) Cinacalcet for hyperparathyroidism in pregnancy and puerperium. J Pediatr Endocrinol Metab 22(8):741\u2013749","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"9","key":"261_CR91","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML, Endocrine S (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97(9):2990\u20133011. doi: 10.1210\/jc.2012-1230","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0261-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-015-0261-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0261-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T02:22:34Z","timestamp":1717813354000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-015-0261-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,28]]},"references-count":91,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["261"],"URL":"https:\/\/doi.org\/10.1007\/s40618-015-0261-3","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,28]]}}}